{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:17:31Z","timestamp":1790392651624,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Polycystic Ovary Syndrome (PCOS) affects a significant proportion of human females worldwide and is characterized by hormonal, metabolic, and reproductive dysfunctions, including infertility, irregular menstrual cycles, acanthosis nigricans, and hirsutism. Mutations in the estrogen receptor genes <jats:italic>ESR1 and ESR2<\/jats:italic>, involved in normal follicular development and ovulation, can contribute to development of the PCOS. The present study focuses on investigating the potential correlation between single nucleotide polymorphisms (SNPs) of <jats:italic>ESR1<\/jats:italic> and <jats:italic>ESR2<\/jats:italic> genes and the incidence of this syndrome.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>For this study, SNPs in <jats:italic>ESR1<\/jats:italic> and <jats:italic>ESR2<\/jats:italic> genes were retrieved from the ENSEMBL database and analyzed for their effect on mutated proteins using different bioinformatics tools including SIFT, PolyPhen, CADD, REVEL, MetaLR, I-Mutant, CELLO2GO, ProtParam, SOPMA, SWISS-MODEL and HDDOCK.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>All the SNPs documented in the present study were deleterious. All the SNPs except rs1583384537, rs1450198518, and rs78255744 decreased protein stability. Two variants rs1463893698 and rs766843910 in the <jats:italic>ESR2<\/jats:italic> gene altered the localization of mutated proteins i.e. in addition to the nucleus, proteins were also found in mitochondria and extracellular, respectively. SNPs rs104893956 in <jats:italic>ESR1<\/jats:italic> and rs140630557, rs140630557, rs1596423459, rs766843910, rs1596405923, rs762454979 and rs1384121511 in <jats:italic>ESR2<\/jats:italic> gene significantly changed the secondary structure of proteins (2D). SNPs that markedly changed 3D configuration included rs1554259481, rs188957694 and rs755667747 in <jats:italic>ESR1<\/jats:italic> gene and rs1463893698, rs140630557, rs1596423459, rs766843910, rs1596405923, rs762454979 and rs1384121511 in <jats:italic>ESR2<\/jats:italic> gene. Variants rs1467954450 (<jats:italic>ESR1<\/jats:italic>) and rs140630557 (<jats:italic>ESR2)<\/jats:italic> were identified to reduce the binding tendency of ESR\u03b1 and \u03b2 receptors with estradiol as reflected by the docking scores i.e. -164.97 and -173.23, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Due to the significant impact on the encoded proteins, these variants might be proposed as biomarkers to predict the likelihood of developing PCOS in the future and for diagnostic purposes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-023-01335-7","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T04:42:11Z","timestamp":1706503331000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Exploring the association of ESR1 and ESR2 gene SNPs with polycystic ovary syndrome in human females: a comprehensive association study"],"prefix":"10.1186","volume":"17","author":[{"given":"Fatima","family":"Muccee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naeem Mahmood","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhail","family":"Razak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayyaba","family":"Afsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fohad Mabood","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huma","family":"Shafique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,29]]},"reference":[{"key":"1335_CR1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","volume":"370","author":"RJ Norman","year":"2007","unstructured":"Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet. 2007;370:685\u201397.","journal-title":"Lancet"},{"key":"1335_CR2","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.tem.2018.08.005","volume":"29","author":"KA Walters","year":"2018","unstructured":"Walters KA, Gilchrist RB, Ledger WL, Teede HJ, Handelsman DJ, Campbell RE. New perspectives on the pathogenesis of PCOS: neuroendocrine origins. Trends Endocrinol Metab. 2018;29:841\u201352.","journal-title":"Trends Endocrinol Metab"},{"key":"1335_CR3","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3390\/genes13071231","volume":"13","author":"F Muccee","year":"2022","unstructured":"Muccee F, Bijou O, Harakeh S, Adawiyah R, Sayyed RZ, Haghshenas L, Alshehri D, Ansari MJ, Ghazanfar S. In-Silico investigation of effects of single-nucleotide polymorphisms in PCOS-associated CYP11A1 gene on mutated proteins. Genes. 2022;13:1231.","journal-title":"Genes"},{"key":"1335_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-020-01861-x","volume":"18","author":"CT Tay","year":"2020","unstructured":"Tay CT, Hart RJ, Hickey M, Moran LJ, Earnest A, Doherty DA, Teede HJ, Joham AE. Updated adolescent diagnostic criteria for polycystic ovary syndrome: impact on prevalence and longitudinal body mass index trajectories from birth to adulthood. BMC Med. 2020;18:1\u201311.","journal-title":"BMC Med"},{"key":"1335_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3054","volume":"34","author":"M Jacewicz-\u015awi\u0119cka","year":"2018","unstructured":"Jacewicz-\u015awi\u0119cka M, Kowalska I. Polycystic ovary syndrome and the risk of cardiometabolic complications in longitudinal studies. Diabetes Metab Res Rev. 2018;34: e3054.","journal-title":"Diabetes Metab Res Rev"},{"key":"1335_CR6","doi-asserted-by":"publisher","first-page":"022","DOI":"10.1055\/s-2007-992921","volume":"26","author":"GN Allahbadia","year":"2008","unstructured":"Allahbadia GN, Merchant R. Polycystic ovary syndrome in the Indian Subcontinent. Semin Reprod Med. 2008;26:022\u201334.","journal-title":"Semin Reprod Med"},{"key":"1335_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.gene.2013.04.040","volume":"524","author":"T Zhang","year":"2013","unstructured":"Zhang T, Liang W, Fang M, Yu J, Ni Y, Li Z. Association of the CAG repeat polymorphisms in androgen receptor gene with polycystic ovary syndrome: a systemic review and meta-analysis. Gene. 2013;524:161\u20137.","journal-title":"Gene"},{"key":"1335_CR8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.fertnstert.2008.07.016","volume":"92","author":"M Pusalkar","year":"2009","unstructured":"Pusalkar M, Meherji P, Gokral J, Chinnaraj S, Maitra A. CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome. Fertil Steril. 2009;92:653\u20139.","journal-title":"Fertil Steril"},{"key":"1335_CR9","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s10815-014-0286-0","volume":"31","author":"CY Peng","year":"2014","unstructured":"Peng CY, Xie HJ, Guo ZF, Nie YL, Chen J, Zhou JM, Yin J. The association between androgen receptor gene CAG polymorphism and polycystic ovary syndrome: a case-control study and meta-analysis. J Assist Reproduct Genet. 2014;31:1211\u20139.","journal-title":"J Assist Reproduct Genet"},{"key":"1335_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/TACG.S200341","volume":"12","author":"MJ Khan","year":"2019","unstructured":"Khan MJ, Ullah A, Basit S. Genetic basis of polycystic ovary syndrome (PCOS): current perspectives. Appl Clin Genet. 2019;12:249.","journal-title":"Appl Clin Genet"},{"key":"1335_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12902-020-0497-6","volume":"20","author":"B Zhang","year":"2020","unstructured":"Zhang B, Zhou W, Shi Y, Zhang J, Cui L, Chen ZJ. Lifestyle and environmental contributions to ovulatory dysfunction in women of polycystic ovary syndrome. BMC Endocr Disord. 2020;20:1\u20137.","journal-title":"BMC Endocr Disord"},{"key":"1335_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43042-019-0031-4","volume":"20","author":"S Ashraf","year":"2019","unstructured":"Ashraf S, Nabi M, Rashid F, Amin S. Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: a review. Egypt J Med Hum Genet. 2019;20:1\u201310.","journal-title":"Egypt J Med Hum Genet"},{"key":"1335_CR13","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1210\/er.2002-0015","volume":"24","author":"V De Leo","year":"2003","unstructured":"De Leo V, La Marca A, Petraglia F. Insulin-lowering agents in the management of polycystic ovary syndrome. Endocr Rev. 2003;24:633\u201367.","journal-title":"Endocr Rev"},{"key":"1335_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/aje\/kwi055","volume":"161","author":"L Gennari","year":"2005","unstructured":"Gennari L, Merlotti D, De Paola V, Calabro A, Becherini L, Martini G, Nuti R. Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review. Am J Epidemiol. 2005;161:307\u201320.","journal-title":"Am J Epidemiol"},{"key":"1335_CR15","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3390\/cells8101123","volume":"8","author":"ZR Tang","year":"2019","unstructured":"Tang ZR, Zhang R, Lian ZX, Deng SL, Yu K. Estrogen-receptor expression and function in female reproductive disease. Cells. 2019;8:1123.","journal-title":"Cells"},{"key":"1335_CR16","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3390\/ijms23010512","volume":"23","author":"S Chauvin","year":"2022","unstructured":"Chauvin S, Cohen-Tannoudji J, Guigon CJ. Estradiol signaling at the heart of folliculogenesis: its potential deregulation in human ovarian pathologies. Int J Mol Sci. 2022;23:512.","journal-title":"Int J Mol Sci"},{"key":"1335_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3390\/cells10020459","volume":"10","author":"XL Xu","year":"2021","unstructured":"Xu XL, Deng SL, Lian ZX, Yu K. Estrogen receptors in polycystic ovary syndrome. Cells. 2021;10:459.","journal-title":"Cells"},{"key":"1335_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coemr.2020.01.003","volume":"12","author":"KA Walters","year":"2020","unstructured":"Walters KA. Polycystic ovary syndrome: Is it androgen or estrogen receptor? Curr Opin Endocr Metab Res. 2020;12:1\u20137.","journal-title":"Curr Opin Endocr Metab Res"},{"key":"1335_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12958-015-0051-y","volume":"13","author":"T Segawa","year":"2015","unstructured":"Segawa T, Teramoto S, Omi K, Miyauchi O, Watanabe Y, Osada H. Changes in estrone and estradiol levels during follicle development: a retrospective large-scale study. Reprod Biol Endocr. 2015;13:1\u20137.","journal-title":"Reprod Biol Endocr"},{"key":"1335_CR20","doi-asserted-by":"publisher","first-page":"8495","DOI":"10.1074\/jbc.RA117.001212","volume":"293","author":"Y Arao","year":"2018","unstructured":"Arao Y, Korach KS. The F domain of estrogen receptor \u03b1 is involved in species-specific, tamoxifen-mediated transactivation. J Biol Chem. 2018;293:8495\u2013507.","journal-title":"J Biol Chem"},{"key":"1335_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12958-022-01029-7","volume":"20","author":"F Liu","year":"2022","unstructured":"Liu F, Tian L, Tan J, Li Z, Qin H, Xu D, Huang Z, Wu X, Chen G, Wu Q. Identification of a novel ESR1 mutation in a Chinese PCOS woman with estrogen insensitivity in IVF treatment. Reprod Biol Endocrinol. 2022;20:157.","journal-title":"Reprod Biol Endocrinol"},{"key":"1335_CR22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ygyno.2006.03.029","volume":"103","author":"A Villavicencio","year":"2006","unstructured":"Villavicencio A, Bacallao K, Avellaira C, Gabler F, Fuentes A, Vega M. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia. Gynecol Oncol. 2006;103:307\u201314.","journal-title":"Gynecol Oncol"},{"key":"1335_CR23","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/S0015-0282(03)00987-7","volume":"80","author":"M Maliqueo","year":"2003","unstructured":"Maliqueo M, Clementi M, Gabler F, Johnson MC, Palomino A, Sir-Petermann T, Vega M. Expression of steroid receptors and proteins related to apoptosis in endometria of women with polycystic ovary syndrome. Fertil Steril. 2003;80:812\u20139.","journal-title":"Fertil Steril"},{"key":"1335_CR24","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1177\/1933719114542015","volume":"22","author":"I Liaqat","year":"2015","unstructured":"Liaqat I, Jahan N, Krikun G, Taylor HS. Genetic polymorphisms in Pakistani women with polycystic ovary syndrome. Reprod Sci. 2015;22:347\u201357.","journal-title":"Reprod Sci"},{"key":"1335_CR25","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3389\/fendo.2018.00504","volume":"9","author":"X Jiao","year":"2018","unstructured":"Jiao X, Chen W, Zhang J, Wang W, Song J, Chen D, Zhu W, Shi Y, Yu X. Variant alleles of the ESR1, PPARG, HMGA2, and MTHFR genes are associated with polycystic ovary syndrome risk in a Chinese population: a case-control study. Front Endocrinol. 2018;9:504.","journal-title":"Front Endocrinol"},{"key":"1335_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.726184","volume":"12","author":"S Zhou","year":"2021","unstructured":"Zhou S, Wen S, Sheng Y, Yang M, Shen X, Chen Y, Kang D, Xu L. Association of estrogen receptor genes polymorphisms with polycystic ovary syndrome: a systematic review and meta-analysis based on observational studies. Front Endocrinol. 2021;12: 726184.","journal-title":"Front Endocrinol"},{"key":"1335_CR27","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1093\/nar\/gkg563","volume":"31","author":"E Gasteiger","year":"2003","unstructured":"Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, Bairoch A. ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 2003;31:3784\u20138.","journal-title":"Nucleic Acids Res"},{"key":"1335_CR28","doi-asserted-by":"publisher","first-page":"W452","DOI":"10.1093\/nar\/gks539","volume":"40","author":"NL Sim","year":"2012","unstructured":"Sim NL, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 2012;40:W452\u20137.","journal-title":"Nucleic Acids Res"},{"key":"1335_CR29","first-page":"21","volume":"76","author":"I Adzhubei","year":"2013","unstructured":"Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet. 2013;76:21\u20137.","journal-title":"Curr Protoc Hum Genet"},{"key":"1335_CR30","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 2019;47:D886\u201394.","journal-title":"Nucleic Acids Res"},{"key":"1335_CR31","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1093\/hmg\/ddu733","volume":"24","author":"C Dong","year":"2015","unstructured":"Dong C, Wei P, Jian X, Gibbs R, Boerwinkle E, Wang K, Liu X. Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. Hum Mol Genet. 2015;24:2125\u201337.","journal-title":"Hum Mol Genet"},{"key":"1335_CR32","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, Musolf A, Li Q, Holzinger E, Karyadi D. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet. 2016;99:877\u201385.","journal-title":"Am J Hum Genet"},{"key":"1335_CR33","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10822-016-9914-3","volume":"30","author":"S Kulshreshtha","year":"2016","unstructured":"Kulshreshtha S, Chaudhary V, Goswami GK, Mathur N. Computational approaches for predicting mutant protein stability. J Comput Aided Mol Des. 2016;30:401\u201312.","journal-title":"J Comput Aided Mol Des"},{"key":"1335_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099368","volume":"9","author":"CS Yu","year":"2014","unstructured":"Yu CS, Cheng CW, Su WC, Chang KC, Huang SW, Hwang JK, Lu CH. CELLO2GO: a web server for protein subCELlular LOcalization prediction with functional gene ontology annotation. PLoS One. 2014;9: e99368.","journal-title":"PLoS One"},{"key":"1335_CR35","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/bioinformatics\/11.6.681","volume":"11","author":"C Geourjon","year":"1995","unstructured":"Geourjon C, Deleage G. SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Bioinform. 1995;11:681\u20134.","journal-title":"Bioinform"},{"key":"1335_CR36","doi-asserted-by":"publisher","first-page":"W460","DOI":"10.1093\/nar\/gkm363","volume":"35","author":"T Ishida","year":"2007","unstructured":"Ishida T, Kinoshita K. PrDOS: prediction of disordered protein regions from amino acid sequence. Nucleic Acids Res. 2007;35:W460\u20134.","journal-title":"Nucleic Acids Res"},{"key":"1335_CR37","first-page":"1548","volume":"18","author":"SS Sheik","year":"2002","unstructured":"Sheik SS, Sundararajan P, Hussain ASZ, Sekar K. Ramachandran plot on the web Bioinform. 2002;18:1548\u20139.","journal-title":"Ramachandran plot on the web Bioinform"},{"key":"1335_CR38","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/pro.5560020916","volume":"2","author":"C Colovos","year":"1993","unstructured":"Colovos C, Yeates TO. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci. 1993;2:1511\u20139.","journal-title":"Protein Sci"},{"key":"1335_CR39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1515\/bmc.2010.022","volume":"1","author":"SA Hollingsworth","year":"2010","unstructured":"Hollingsworth SA, Karplus PA. A fresh look at the Ramachandran plot and the occurrence of standard structures in proteins. Biomol Concepts. 2010;1:271\u201383.","journal-title":"Biomol Concepts"},{"key":"1335_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.144560","volume":"741","author":"Z Douma","year":"2020","unstructured":"Douma Z, Dallel M, Bahia W, Salem AB, Ali FHB, Almawi WY, Lautier C, Haydar S, Grigorescu F, Mahjoub T. Association of estrogen receptor gene variants (ESR1 and ESR2) with polycystic ovary syndrome in Tunisia. Gene. 2020;741: 144560.","journal-title":"Gene"},{"key":"1335_CR41","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.3390\/ijerph19053114","volume":"19","author":"R Mir","year":"2022","unstructured":"Mir R, Tayeb FJ, Barnawi J, Jalal MM, Saeedi NH, Hamadi A, Altayar MA, Alshammari SE, Mtiraoui N, Ali ME. Biochemical characterization and molecular determination of estrogen Receptor-\u03b1 (ESR1 PvuII-rs2234693 T> C) and MiRNA-146a (rs2910164 C> G) polymorphic gene variations and their association with the risk of polycystic ovary syndrome. Int J Environ Res Public Health. 2022;19:3114.","journal-title":"Int J Environ Res Public Health"},{"key":"1335_CR42","first-page":"26","volume":"18","author":"EFA Al-Jumaili","year":"2019","unstructured":"Al-Jumaili EFA. Allelic estrogen receptor beta (ESR2) gene association with Polycystic Ovary Syndrome in unmarried Iraqi female of Baghdad governorate. Iraqi J Biotechnol. 2019;18:26\u201332.","journal-title":"Iraqi J Biotechnol."},{"key":"1335_CR43","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12010-011-9420-y","volume":"166","author":"VK Morya","year":"2012","unstructured":"Morya VK, Yadav S, Kim EK, Yadav D. In silico characterization of alkaline proteases from different species of Aspergillus. Appl Biochem Biotechnol. 2012;166:243\u201357.","journal-title":"Appl Biochem Biotechnol"},{"key":"1335_CR44","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2174\/0929866526666190228144219","volume":"26","author":"DG Gamage","year":"2019","unstructured":"Gamage DG, Gunaratne A, Periyannan GR, Russell TG. Applicability of instability index for in vitro protein stability prediction. Protein Pept Lett. 2019;26:339\u201347.","journal-title":"Protein Pept Lett"},{"key":"1335_CR45","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1016\/j.csbj.2021.07.012","volume":"19","author":"YT Jin","year":"2021","unstructured":"Jin YT, Jin TY, Zhang ZL, Ye YN, Deng Z, Wang J, Guo FB. Quantitative elucidation of associations between nucleotide identity and physicochemical properties of amino acids and the functional insight. J Comput Struct Biotechnol. 2021;19:4042\u20138.","journal-title":"J Comput Struct Biotechnol"},{"key":"1335_CR46","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1530\/JME-17-0041","volume":"59","author":"RS Campello","year":"2017","unstructured":"Campello RS, F\u00e1tima LA, Barreto-Andrade JN, Lucas TF, Mori RC, Porto CS, Machado UF. Estradiol-induced regulation of GLUT4 in 3T3-L1 cells: involvement of ESR1 and AKT activation. J Mol Endocrinol. 2017;59:257\u201368.","journal-title":"J Mol Endocrinol"},{"key":"1335_CR47","doi-asserted-by":"publisher","first-page":"19712","DOI":"10.1038\/s41598-022-17383-w","volume":"12","author":"I Uzar","year":"2022","unstructured":"Uzar I, Bogacz A, Sowi\u0144ska-Przepiera E, Kotrych K, Wolek M, Sulikowski T, Kami\u0144ski A. The influence of ESR1 polymorphisms on selected hormonal, metabolic and mineral balance markers in women with hyperandrogenism. Sci Rep. 2022;12:19712.","journal-title":"Sci Rep"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01335-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-023-01335-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01335-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T15:05:23Z","timestamp":1706540723000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-023-01335-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,29]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1335"],"URL":"https:\/\/doi.org\/10.1186\/s13048-023-01335-7","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,29]]},"assertion":[{"value":"10 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}